D. E. Shaw & Co., Inc. Novavax Inc Transaction History

D. E. Shaw & Co., Inc.

$125 Billion
Q2 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Novavax Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 267,200 shares of NVAX stock, worth $2.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

267,200

Previous 3,260,908 91.81%

Holding current value

$2.27 Million

Previous $20.9 Million 91.95%

% of portfolio

0.0%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$5.43 - $7.74 $3.69 Million - $5.26 Million	680,052 Added 20.85%	3,940,960 $24.8 Million
Q1 2025 May 15, 2025	SELL	$6.41 - $10.82 $16.2 Million - $27.4 Million	-2,529,346 Reduced 43.68%	3,260,908 $20.9 Million
Q4 2024 Feb 14, 2025	SELL	$7.22 - $14.68 $1.06 Million - $2.16 Million	-146,911 Reduced 2.47%	5,790,254 $46.6 Million
Q3 2024 Nov 14, 2024	SELL	$10.71 - $17.11 $4.12 Million - $6.59 Million	-384,910 Reduced 6.09%	5,937,165 $75 Million
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $24.1 Million - $130 Million	6,207,724 Added 5428.66%	6,322,075 $80 Million
Q1 2024 May 15, 2024	BUY	$3.76 - $6.02 $44,435 - $71,144	11,818 Added 11.53%	114,351 $546,000
Q4 2023 Feb 14, 2024	BUY	$4.8 - $7.67 $417,292 - $666,799	86,936 Added 557.39%	102,533 $492,000
Q3 2023 Nov 14, 2023	BUY	$6.81 - $9.74 $106,215 - $151,914	15,597 New	15,597 $112,000
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $1.2 Million - $3.39 Million	135,518 Added 27.29%	632,099 $6.5 Million
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $5.02 Million - $21 Million	275,702 Added 124.82%	496,581 $9.04 Million
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $3.41 Million - $7.08 Million	93,999 Added 74.08%	220,879 $11.4 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $4.29 Million - $8.8 Million	61,547 Added 94.21%	126,880 $9.35 Million
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $2.45 Million - $3.73 Million	-13,790 Reduced 17.43%	65,333 $13.5 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $3.82 Million - $8.12 Million	31,529 Added 66.25%	79,123 $16.8 Million
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $4.79 Million - $13.6 Million	42,355 Added 808.46%	47,594 $8.63 Million
Q3 2020 Nov 16, 2020	SELL	$79.44 - $178.51 $78.6 Million - $177 Million	-989,509 Reduced 99.47%	5,239 $568,000
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $11.6 Million - $69.8 Million	834,271 Added 519.87%	994,748 $82.9 Million
Q1 2020 May 15, 2020	SELL	$3.93 - $16.0 $137,219 - $558,656	-34,916 Reduced 17.87%	160,477 $2.18 Million
Q4 2019 Feb 14, 2020	BUY	$3.69 - $5.22 $623,104 - $881,464	168,863 Added 636.5%	195,393 $778,000
Q3 2019 Nov 14, 2019	BUY	$4.02 - $7.84 $106,650 - $207,995	26,530 New	26,530 $133,000

Others Institutions Holding NVAX

# of Institutions

315

Shares Held

94.7M

Call Options Held

6.11M

Put Options Held

10.5M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $663M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account